IDL Diagnostics held annual general meeting
The meeting approved financial reports, elected board members and authorized a share issue.
See the latest news and media coverage for IDL Diagnostics. We track all announcements, press releases, and industry mentions in real time, all in one place.
Swedish diagnostics company for oncological and bacterial diseases
idldiagnostics.comLast updated
In short: IDL Diagnostics appointed Gustav Sten as CEO following record quarterly revenue and significant international expansion in Asia and the Middle East.
The meeting approved financial reports, elected board members and authorized a share issue.
He discusses his priorities focusing on commercialization and growth.
He succeeds Anders Hultman and will assume the role on May 28, 2026.
The meeting is held on 28 May 2026 in Bromma. The nomination committee proposes re-election of board members and authorisation for emissions.
IDL Diagnostics AB is a in vitro diagnostics company, which engages in the monitoring of hematological malignancies, breast cancer, and other solid tumors. Its products...
IDL Diagnostics today announces that the Board of Directors has appointed Gustav Sten as the new Chief Executive Officer (CEO). Gustav Sten will assume the...
A word från the CEO "IDL Diagnostics has started 2026 with the strongest quarter in the company's history, and the clear growth trend that we...
Integrated Diagnostics Holdings plc (LON:IDHC – Get Free Report)’s share price crossed above its 50 day moving average during trading on Friday . The stock...
Track IDL Diagnostics and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.